Stockscreener 앱 받기
10.38
0.95%
-0.10
시장 영업 전:
10.32
-0.06
-0.58%
전일 마감가:
$10.48
열려 있는:
$10.48
하루 거래량:
1.35M
Relative Volume:
0.85
시가총액:
$959.11M
수익:
$2.98B
순이익/손실:
$-300.00M
주가수익비율:
-3.0529
EPS:
-3.4
순현금흐름:
$225.00M
1주 성능:
+0.39%
1개월 성능:
-35.37%
6개월 성능:
-1.24%
1년 성능:
-5.29%
1일 변동 폭
$10.14
$10.76
1주일 범위
$9.05
$11.11
52주 변동 폭
$3.97
$18.67
Fortrea Holdings Inc Stock (FTRE) Company Profile
명칭
Fortrea Holdings Inc
전화
877-495-0816
주소
8 MOORE DRIVE, DURHAM
Compare FTRE vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FTRE
Fortrea Holdings Inc
|
10.38 | 968.35M | 2.98B | -300.00M | 225.00M | -3.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.89 | 120.48B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.50 | 81.05B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
749.56 | 46.33B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.30 | 42.26B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
299.02 | 32.87B | 5.36B | 287.73M | 924.18M | 2.5229 |
Fortrea Holdings Inc Stock (FTRE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-08 | 업그레이드 | Truist | Hold → Buy |
| 2026-01-06 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-12-15 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2025-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-08-04 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2025-05-02 | 개시 | Truist | Hold |
| 2025-04-10 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2024-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-12-06 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-09-25 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-08-08 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2024-07-24 | 재개 | Barclays | Equal Weight |
| 2024-06-06 | 개시 | Goldman | Neutral |
| 2024-05-29 | 개시 | TD Cowen | Hold |
| 2024-05-28 | 개시 | Mizuho | Neutral |
| 2024-03-22 | 개시 | Robert W. Baird | Neutral |
| 2024-03-06 | 개시 | Deutsche Bank | Hold |
| 2024-01-05 | 개시 | William Blair | Mkt Perform |
| 2024-01-04 | 개시 | Jefferies | Buy |
| 2023-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-12-01 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-11-14 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2023-10-19 | 개시 | Citigroup | Neutral |
| 2023-09-14 | 개시 | Evercore ISI | In-line |
| 2023-08-16 | 개시 | Barclays | Equal Weight |
| 2023-08-07 | 개시 | BofA Securities | Underperform |
모두보기
Fortrea Holdings Inc 주식(FTRE)의 최신 뉴스
Is Fortrea Holdings (FTRE) Now An Opportunity After A 38.4% Share Price Slide? - simplywall.st
S P Trends: How sensitive is Fortrea Holdings Inc to inflation2025 Trade Ideas & AI Based Buy and Sell Signals - baoquankhu1.vn
FTRE Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Fortrea (FTRE) Q4 2025 Earnings Call Transcript - AOL.com
Q4 Earnings Highs And Lows: Fortrea (NASDAQ:FTRE) Vs The Rest Of The Drug Development Inputs & Services Stocks - Finviz
Fortrea Holdings Inc. (FTRE) 2026 Guidance Assumes Stable FX Rates from End-2025 - Finviz
A Look At Fortrea Holdings (FTRE) Valuation After Weak Q4 Results And Soft 2025–2026 Guidance - simplywall.st
2026-03-01 | Bronstein, Gewirtz & Grossman, LLC Encourages Fortrea Holdings, Inc. (FTRE) Shareholders to Inquire about Securities Investigation | NDAQ:FTRE | Press Release - Stockhouse
Behavioral Patterns of FTRE and Institutional Flows - Stock Traders Daily
Deep Dive Into Fortrea Holdings Stock: Analyst Perspectives (7 Ratings) - Sahm
Fortrea Holdings Inc. (FTRE) Receives a Hold from Barclays - The Globe and Mail
Fortrea Holdings Inc. (FTRE): Investor Outlook With A Promising 37.88% Potential Upside - DirectorsTalk Interviews
Barclays Issues Pessimistic Forecast for Fortrea (NASDAQ:FTRE) Stock Price - MarketBeat
Fortrea Holdings Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:FTRE) 2026-02-27 - Seeking Alpha
Deutsche Bank Adjusts Fortrea Price Target to $14 From $16, Maintains Hold Rating - marketscreener.com
Fortrea (NASDAQ:FTRE) Price Target Lowered to $16.00 at Robert W. Baird - MarketBeat
Fortrea Holdings Inc. (NASDAQ:FTRE) Q4 2025 Earnings Call Transcript - Insider Monkey
Fortrea (NASDAQ:FTRE) Posts Quarterly Earnings Results, Misses Expectations By $0.07 EPS - MarketBeat
Fortrea Q4 Earnings Call Highlights - MarketBeat
Fortrea shares slip after revenue miss overshadows quarterly results - MSN
Bronstein, Gewirtz & Grossman, LLC Is Investigating Fortrea Holdings, Inc. (FTRE) And Encourages Shareholders to Connect - ACCESS Newswire
Earnings call transcript: Fortrea Holdings Q4 2025 misses forecasts, stock dips - Investing.com
Fortrea Q4 2025 slides: revenue dips, transformation advances amid headwinds - Investing.com
Fortrea (NASDAQ:FTRE) Shares Gap Down on Disappointing Earnings - MarketBeat
Fortrea Q4 2025 slides: revenue dips, transformation advances amid headwinds By Investing.com - Investing.com South Africa
Fortrea Holdings Inc. (FTRE) Q4 Earnings and Revenues Lag Estimates - Yahoo Finance
Fortrea (NASDAQ:FTRE) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings - Finviz
Fortrea Holdings Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Fortrea Holdings Inc. Provides Earnings Guidance for the Fiscal Year 2026 - marketscreener.com
FORTREA ($FTRE) Releases Q4 2025 Earnings - Quiver Quantitative
Fortrea stock edges down as revenue misses estimates despite meeting EPS By Investing.com - Investing.com South Africa
Fortrea stock edges down as revenue misses estimates despite meeting EPS - Investing.com Nigeria
Earnings Flash (FTRE) Fortrea Holdings Inc. Posts Q4 Adjusted EPS $0.09 per Share, vs. FactSet Est of $0.17 - marketscreener.com
Fortrea Reports Fourth Quarter and Full Year 2025 Financial Results, Aligning with Full-Year Targets - Quiver Quantitative
Fortrea Reports Fourth Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance - TradingView
Fortrea (Nasdaq: FTRE) books $986.2M 2025 loss after $797.9M goodwill hit - Stock Titan
Contract research firm Fortrea posts $986M loss, sets 2026 EBITDA goal - Stock Titan
Earnings To Watch: Fortrea (FTRE) Reports Q4 Results Tomorrow - Finviz
Counterpoint Mutual Funds LLC Acquires Shares of 103,646 Fortrea Holdings Inc. $FTRE - MarketBeat
iRhythm, agilon health, GoodRx, Fortrea, and Myriad Genetics Stocks Trade Down, What You Need To Know - Finviz
Is Fortrea (FTRE) Recasting Its Executive Bench to Sharpen the Drug Development Efficiency Story? - Yahoo Finance
2026-02-22 | Bronstein, Gewirtz & Grossman, LLC Encourages Fortrea Holdings, Inc. (FTRE) Stockholders to Inquire about Securities Investigation | NDAQ:FTRE | Press Release - Stockhouse
Is Fortrea Holdings Inc. stock a bargain at current levelsJuly 2025 Earnings & Fast Moving Stock Trade Plans - mfd.ru
Fortrea Holdings Inc. (FTRE) Stock Analysis: A Potential 49% Upside Beckons Investors - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fortrea Holdings, Inc. (FTRE) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Fortrea (FTRE) Expected to Announce Earnings on Thursday - MarketBeat
3 Reasons to Sell FTRE and 1 Stock to Buy Instead - Yahoo Finance
Eagle Health Investments LP Invests $8.33 Million in Fortrea Holdings Inc. $FTRE - MarketBeat
Fortrea Holdings Inc. (NASDAQ:FTRE) Receives Average Rating of "Hold" from Analysts - MarketBeat
Fortrea Expands Executive Team, Appointing Oren Cohen as - GlobeNewswire
Fortrea appoints Oren Cohen as chief medical officer and Scott Dove as president of clinical pharmacology services - marketscreener.com
Fortrea Holdings Inc (FTRE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.11%
6.00%
자본화:
|
볼륨(24시간):